However, the higher-value Core+ behavioral tier ended the quarter with 541,000 subscribers, a 13.9% increase from the prior-year period. During the quarter, Weight Watchers expanded access to Med+ through LillyDirect and said the offering now supports eligible beneficiaries through the Medicare GLP-1 Bridge Program. Volkmann said Weight Watchers Med+ members prescribed GLP-1 medications reported more than 30% more average body-weight loss at 12 months than select industry competitors. Weight Watchers expects marketing spending to be lowest in the third quarter before increasing in the fourth quarter ahead of the next peak season. About WW International (NASDAQ:WW)WW International, Inc (NASDAQ: WW) is a global wellness and weight management company that provides a range of subscription-based programs, digital tools and personalized coaching services.